nodes	percent_of_prediction	percent_of_DWPC	metapath
Baclofen—GABBR2—hindbrain—Parkinson's disease	0.0513	0.175	CbGeAlD
Baclofen—GABBR2—brainstem—Parkinson's disease	0.0294	0.1	CbGeAlD
Baclofen—GABBR2—forebrain—Parkinson's disease	0.0284	0.0968	CbGeAlD
Baclofen—GABBR2—medulla oblongata—Parkinson's disease	0.0205	0.0699	CbGeAlD
Baclofen—GABBR2—midbrain—Parkinson's disease	0.0187	0.0639	CbGeAlD
Baclofen—GABBR2—spinal cord—Parkinson's disease	0.0183	0.0623	CbGeAlD
Baclofen—GABBR2—head—Parkinson's disease	0.0163	0.0554	CbGeAlD
Baclofen—GABBR2—nervous system—Parkinson's disease	0.0154	0.0525	CbGeAlD
Baclofen—GABBR2—central nervous system—Parkinson's disease	0.0148	0.0506	CbGeAlD
Baclofen—GABBR2—cerebellum—Parkinson's disease	0.0145	0.0494	CbGeAlD
Baclofen—GABBR2—brain—Parkinson's disease	0.0118	0.0401	CbGeAlD
Baclofen—GABBR1—medulla oblongata—Parkinson's disease	0.0104	0.0353	CbGeAlD
Baclofen—GABBR1—midbrain—Parkinson's disease	0.00946	0.0322	CbGeAlD
Baclofen—GABBR1—spinal cord—Parkinson's disease	0.00923	0.0315	CbGeAlD
Baclofen—GABBR1—cerebellum—Parkinson's disease	0.00732	0.0249	CbGeAlD
Baclofen—GABBR1—brain—Parkinson's disease	0.00595	0.0203	CbGeAlD
Baclofen—GABBR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIK1—Parkinson's disease	0.00558	0.0079	CbGpPWpGaD
Baclofen—GABBR2—Transmission across Chemical Synapses—DLG1—Parkinson's disease	0.00536	0.00759	CbGpPWpGaD
Baclofen—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ4—Parkinson's disease	0.00532	0.00753	CbGpPWpGaD
Baclofen—GABBR1—Neuronal System—HCN3—Parkinson's disease	0.00476	0.00674	CbGpPWpGaD
Baclofen—GABBR2—Neuronal System—KCNJ4—Parkinson's disease	0.00476	0.00674	CbGpPWpGaD
Baclofen—GABBR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIK2—Parkinson's disease	0.00474	0.00672	CbGpPWpGaD
Baclofen—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG1—Parkinson's disease	0.00459	0.0065	CbGpPWpGaD
Baclofen—GABBR2—Transmission across Chemical Synapses—GRIK1—Parkinson's disease	0.00419	0.00594	CbGpPWpGaD
Baclofen—GABBR2—Neuronal System—DLG1—Parkinson's disease	0.00411	0.00581	CbGpPWpGaD
Baclofen—GABBR1—Transmission across Chemical Synapses—KCNJ4—Parkinson's disease	0.004	0.00566	CbGpPWpGaD
Baclofen—GABBR2—G alpha (i) signalling events—GRM4—Parkinson's disease	0.00389	0.00551	CbGpPWpGaD
Baclofen—GABBR2—G alpha (i) signalling events—PENK—Parkinson's disease	0.00369	0.00522	CbGpPWpGaD
Baclofen—GABBR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—Parkinson's disease	0.00364	0.00515	CbGpPWpGaD
Baclofen—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIK1—Parkinson's disease	0.00359	0.00509	CbGpPWpGaD
Baclofen—GABBR2—Transmission across Chemical Synapses—GRIK2—Parkinson's disease	0.00357	0.00505	CbGpPWpGaD
Baclofen—GABBR2—GPCR ligand binding—GPR37—Parkinson's disease	0.00346	0.0049	CbGpPWpGaD
Baclofen—GABBR2—Transmission across Chemical Synapses—SLC18A2—Parkinson's disease	0.00345	0.00489	CbGpPWpGaD
Baclofen—GABBR1—Transmission across Chemical Synapses—DLG1—Parkinson's disease	0.00345	0.00489	CbGpPWpGaD
Baclofen—GABBR2—G alpha (i) signalling events—PDYN—Parkinson's disease	0.00337	0.00477	CbGpPWpGaD
Baclofen—SLC22A8—head—Parkinson's disease	0.00324	0.011	CbGeAlD
Baclofen—GABBR2—Neuronal System—GRIK1—Parkinson's disease	0.00321	0.00455	CbGpPWpGaD
Baclofen—GABBR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—Parkinson's disease	0.00313	0.00443	CbGpPWpGaD
Baclofen—SLC22A8—nervous system—Parkinson's disease	0.00307	0.0105	CbGeAlD
Baclofen—GABBR1—Neuronal System—KCNJ4—Parkinson's disease	0.00307	0.00434	CbGpPWpGaD
Baclofen—GABBR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2B—Parkinson's disease	0.00306	0.00433	CbGpPWpGaD
Baclofen—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIK2—Parkinson's disease	0.00306	0.00433	CbGpPWpGaD
Baclofen—SLC22A8—central nervous system—Parkinson's disease	0.00296	0.0101	CbGeAlD
Baclofen—GABBR2—Transmission across Chemical Synapses—CHRNA4—Parkinson's disease	0.00273	0.00387	CbGpPWpGaD
Baclofen—GABBR2—Neuronal System—GRIK2—Parkinson's disease	0.00273	0.00387	CbGpPWpGaD
Baclofen—GABBR1—Transmission across Chemical Synapses—GRIK1—Parkinson's disease	0.0027	0.00383	CbGpPWpGaD
Baclofen—GABBR2—Neuronal System—SLC18A2—Parkinson's disease	0.00265	0.00375	CbGpPWpGaD
Baclofen—GABBR1—Neuronal System—DLG1—Parkinson's disease	0.00265	0.00375	CbGpPWpGaD
Baclofen—GABBR1—G alpha (i) signalling events—GRM4—Parkinson's disease	0.00251	0.00355	CbGpPWpGaD
Baclofen—GABBR2—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.00251	0.00355	CbGpPWpGaD
Baclofen—GABBR1—G alpha (i) signalling events—PENK—Parkinson's disease	0.00238	0.00336	CbGpPWpGaD
Baclofen—GABBR2—GPCR ligand binding—GRM4—Parkinson's disease	0.00235	0.00333	CbGpPWpGaD
Baclofen—GABBR2—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.00235	0.00333	CbGpPWpGaD
Baclofen—SLC22A8—brain—Parkinson's disease	0.00235	0.008	CbGeAlD
Baclofen—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—Parkinson's disease	0.00234	0.00332	CbGpPWpGaD
Baclofen—GABBR2—G alpha (i) signalling events—HTR1A—Parkinson's disease	0.00231	0.00327	CbGpPWpGaD
Baclofen—GABBR2—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.0023	0.00325	CbGpPWpGaD
Baclofen—GABBR1—Transmission across Chemical Synapses—GRIK2—Parkinson's disease	0.0023	0.00325	CbGpPWpGaD
Baclofen—GABBR2—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.00226	0.00321	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—GPR37—Parkinson's disease	0.00223	0.00316	CbGpPWpGaD
Baclofen—GABBR2—GPCR ligand binding—PENK—Parkinson's disease	0.00223	0.00316	CbGpPWpGaD
Baclofen—GABBR1—Transmission across Chemical Synapses—SLC18A2—Parkinson's disease	0.00223	0.00315	CbGpPWpGaD
Baclofen—GABBR1—G alpha (i) signalling events—PDYN—Parkinson's disease	0.00217	0.00308	CbGpPWpGaD
Baclofen—GABBR2—G alpha (i) signalling events—DRD3—Parkinson's disease	0.00216	0.00306	CbGpPWpGaD
Baclofen—GABBR2—Neuronal System—CHRNA4—Parkinson's disease	0.00209	0.00296	CbGpPWpGaD
Baclofen—GABBR1—Neuronal System—GRIK1—Parkinson's disease	0.00207	0.00293	CbGpPWpGaD
Baclofen—GABBR2—GPCR ligand binding—PDYN—Parkinson's disease	0.00204	0.00289	CbGpPWpGaD
Baclofen—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—Parkinson's disease	0.00202	0.00285	CbGpPWpGaD
Baclofen—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2B—Parkinson's disease	0.00197	0.00279	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—DGKQ—Parkinson's disease	0.00196	0.00277	CbGpPWpGaD
Baclofen—GABBR2—G alpha (i) signalling events—DRD2—Parkinson's disease	0.00196	0.00277	CbGpPWpGaD
Baclofen—GABBR2—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.00193	0.00273	CbGpPWpGaD
Baclofen—GABBR2—Neuronal System—HSPA8—Parkinson's disease	0.00192	0.00272	CbGpPWpGaD
Baclofen—GABBR2—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.00191	0.00271	CbGpPWpGaD
Baclofen—GABBR2—GPCR ligand binding—GRM5—Parkinson's disease	0.0019	0.00269	CbGpPWpGaD
Baclofen—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC18A2—Parkinson's disease	0.00182	0.00258	CbGpPWpGaD
Baclofen—GABBR2—Neuronal System—DLG4—Parkinson's disease	0.0018	0.00255	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—DGKQ—Parkinson's disease	0.00178	0.00252	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—GPR37—Parkinson's disease	0.00178	0.00252	CbGpPWpGaD
Baclofen—GABBR1—Transmission across Chemical Synapses—CHRNA4—Parkinson's disease	0.00176	0.00249	CbGpPWpGaD
Baclofen—GABBR2—Neuronal System—GRIN2B—Parkinson's disease	0.00176	0.00249	CbGpPWpGaD
Baclofen—GABBR1—Neuronal System—GRIK2—Parkinson's disease	0.00176	0.00249	CbGpPWpGaD
Baclofen—GABBR2—Neuronal System—SLC6A3—Parkinson's disease	0.00174	0.00246	CbGpPWpGaD
Baclofen—GABBR1—Neuronal System—SLC18A2—Parkinson's disease	0.00171	0.00241	CbGpPWpGaD
Baclofen—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—Parkinson's disease	0.00168	0.00238	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.00163	0.0023	CbGpPWpGaD
Baclofen—GABBR1—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.00161	0.00229	CbGpPWpGaD
Baclofen—GABBR2—GPCR ligand binding—ADORA2A—Parkinson's disease	0.00161	0.00228	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—GRM4—Parkinson's disease	0.00152	0.00215	CbGpPWpGaD
Baclofen—GABBR1—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.00151	0.00214	CbGpPWpGaD
Baclofen—GABBR1—G alpha (i) signalling events—HTR1A—Parkinson's disease	0.00149	0.00211	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—GRK5—Parkinson's disease	0.00148	0.0021	CbGpPWpGaD
Baclofen—GABBR1—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.00148	0.0021	CbGpPWpGaD
Baclofen—GABBR2—Neuronal System—COMT—Parkinson's disease	0.00148	0.00209	CbGpPWpGaD
Baclofen—GABBR2—Neuronal System—MAOA—Parkinson's disease	0.00146	0.00207	CbGpPWpGaD
Baclofen—GABBR1—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.00146	0.00207	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—PENK—Parkinson's disease	0.00144	0.00204	CbGpPWpGaD
Baclofen—GABBR2—GPCR ligand binding—HTR1A—Parkinson's disease	0.0014	0.00198	CbGpPWpGaD
Baclofen—GABBR1—G alpha (i) signalling events—DRD3—Parkinson's disease	0.00139	0.00197	CbGpPWpGaD
Baclofen—GABBR2—GPCR ligand binding—TAC1—Parkinson's disease	0.00138	0.00195	CbGpPWpGaD
Baclofen—GABBR2—GPCR ligand binding—DRD1—Parkinson's disease	0.00135	0.00191	CbGpPWpGaD
Baclofen—GABBR1—Neuronal System—CHRNA4—Parkinson's disease	0.00135	0.00191	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—GRK5—Parkinson's disease	0.00135	0.00191	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—GRM4—Parkinson's disease	0.00133	0.00188	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—PDYN—Parkinson's disease	0.00132	0.00186	CbGpPWpGaD
Baclofen—GABBR2—GPCR ligand binding—DRD3—Parkinson's disease	0.00131	0.00185	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—VPS35—Parkinson's disease	0.00127	0.00179	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—PENK—Parkinson's disease	0.00126	0.00179	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—DGKQ—Parkinson's disease	0.00126	0.00179	CbGpPWpGaD
Baclofen—GABBR1—G alpha (i) signalling events—DRD2—Parkinson's disease	0.00126	0.00178	CbGpPWpGaD
Baclofen—GABBR1—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.00124	0.00176	CbGpPWpGaD
Baclofen—GABBR1—Neuronal System—HSPA8—Parkinson's disease	0.00124	0.00175	CbGpPWpGaD
Baclofen—GABBR1—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.00123	0.00174	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—GRM5—Parkinson's disease	0.00122	0.00173	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—GRM4—Parkinson's disease	0.00121	0.00171	CbGpPWpGaD
Baclofen—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Parkinson's disease	0.0012	0.00169	CbGpPWpGaD
Baclofen—GABBR2—GPCR ligand binding—HTR7—Parkinson's disease	0.00118	0.00168	CbGpPWpGaD
Baclofen—GABBR2—GPCR ligand binding—DRD2—Parkinson's disease	0.00118	0.00168	CbGpPWpGaD
Baclofen—GABBR1—Neuronal System—DLG4—Parkinson's disease	0.00116	0.00164	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—PDYN—Parkinson's disease	0.00115	0.00163	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—PENK—Parkinson's disease	0.00115	0.00162	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—DGKQ—Parkinson's disease	0.00115	0.00162	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—GPR37—Parkinson's disease	0.00115	0.00162	CbGpPWpGaD
Baclofen—GABBR1—Neuronal System—GRIN2B—Parkinson's disease	0.00113	0.00161	CbGpPWpGaD
Baclofen—GABBR1—Neuronal System—SLC6A3—Parkinson's disease	0.00112	0.00158	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—GRM5—Parkinson's disease	0.00107	0.00152	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—GPR37—Parkinson's disease	0.00105	0.00149	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—DGKQ—Parkinson's disease	0.00105	0.00149	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.00105	0.00148	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—PDYN—Parkinson's disease	0.00105	0.00148	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—ADORA2A—Parkinson's disease	0.00104	0.00147	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—GRM5—Parkinson's disease	0.000974	0.00138	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PPP1R1B—Parkinson's disease	0.00096	0.00136	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—GRK5—Parkinson's disease	0.000956	0.00135	CbGpPWpGaD
Baclofen—GABBR1—Neuronal System—COMT—Parkinson's disease	0.000951	0.00135	CbGpPWpGaD
Baclofen—GABBR2—GPCR ligand binding—EDN1—Parkinson's disease	0.000948	0.00134	CbGpPWpGaD
Baclofen—GABBR1—Neuronal System—MAOA—Parkinson's disease	0.000944	0.00134	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.000912	0.00129	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—HTR1A—Parkinson's disease	0.000902	0.00128	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—TAC1—Parkinson's disease	0.000888	0.00126	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—DRD1—Parkinson's disease	0.000871	0.00123	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—GRK5—Parkinson's disease	0.000868	0.00123	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—GRM4—Parkinson's disease	0.000857	0.00121	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—DRD3—Parkinson's disease	0.000844	0.00119	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—RIT2—Parkinson's disease	0.000839	0.00119	CbGpPWpGaD
Baclofen—GABBR2—GPCR ligand binding—HTR2A—Parkinson's disease	0.000829	0.00117	CbGpPWpGaD
Baclofen—SLC22A8—SLC-mediated transmembrane transport—SLC18A2—Parkinson's disease	0.000828	0.00117	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—ADORA2A—Parkinson's disease	0.000828	0.00117	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—VPS35—Parkinson's disease	0.000817	0.00116	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—PENK—Parkinson's disease	0.000813	0.00115	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—GRK5—Parkinson's disease	0.000796	0.00113	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.000793	0.00112	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.000793	0.00112	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—HTR1A—Parkinson's disease	0.000791	0.00112	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—TAC1—Parkinson's disease	0.000779	0.0011	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—GRM4—Parkinson's disease	0.000779	0.0011	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—DRD1—Parkinson's disease	0.000764	0.00108	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—HTR7—Parkinson's disease	0.000763	0.00108	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—DRD2—Parkinson's disease	0.000763	0.00108	CbGpPWpGaD
Baclofen—SLC22A8—SLC-mediated transmembrane transport—CP—Parkinson's disease	0.000762	0.00108	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—PDYN—Parkinson's disease	0.000743	0.00105	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—DRD3—Parkinson's disease	0.00074	0.00105	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—PENK—Parkinson's disease	0.000738	0.00104	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—HTR1A—Parkinson's disease	0.000718	0.00102	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—GRM4—Parkinson's disease	0.000714	0.00101	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—TAC1—Parkinson's disease	0.000708	0.001	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—DRD1—Parkinson's disease	0.000694	0.000982	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—GRM5—Parkinson's disease	0.000691	0.000978	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000691	0.000978	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PENK—Parkinson's disease	0.000677	0.000958	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—DGKQ—Parkinson's disease	0.000677	0.000958	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—MAG—Parkinson's disease	0.000677	0.000958	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—GPR37—Parkinson's disease	0.000677	0.000958	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—PDYN—Parkinson's disease	0.000675	0.000956	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—DRD3—Parkinson's disease	0.000672	0.000952	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—DRD2—Parkinson's disease	0.000669	0.000948	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—HTR7—Parkinson's disease	0.000669	0.000948	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000628	0.000889	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—GRM5—Parkinson's disease	0.000628	0.000889	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000619	0.000876	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PDYN—Parkinson's disease	0.000619	0.000876	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—EDN1—Parkinson's disease	0.000611	0.000865	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—DRD2—Parkinson's disease	0.000608	0.000861	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—HTR7—Parkinson's disease	0.000608	0.000861	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.000588	0.000832	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—GFAP—Parkinson's disease	0.000582	0.000824	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—GRM5—Parkinson's disease	0.000575	0.000815	CbGpPWpGaD
Baclofen—SLC22A8—SLC-mediated transmembrane transport—SLC6A3—Parkinson's disease	0.000543	0.000769	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—RIT2—Parkinson's disease	0.000541	0.000766	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—EDN1—Parkinson's disease	0.000536	0.000759	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—HTR2A—Parkinson's disease	0.000534	0.000757	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—ADORA2A—Parkinson's disease	0.000534	0.000755	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—GRK5—Parkinson's disease	0.000513	0.000726	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—HTR1A—Parkinson's disease	0.00051	0.000722	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—FGF20—Parkinson's disease	0.000504	0.000714	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—TAC1—Parkinson's disease	0.000502	0.000711	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—DRD1—Parkinson's disease	0.000492	0.000697	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—ADORA2A—Parkinson's disease	0.000489	0.000693	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—EDN1—Parkinson's disease	0.000487	0.000689	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—DRD3—Parkinson's disease	0.000477	0.000675	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000469	0.000664	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—HTR1A—Parkinson's disease	0.000463	0.000656	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—GRM4—Parkinson's disease	0.00046	0.000651	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—TAC1—Parkinson's disease	0.000456	0.000646	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—INSR—Parkinson's disease	0.000451	0.000639	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—DRD1—Parkinson's disease	0.000447	0.000633	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000445	0.000631	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PENK—Parkinson's disease	0.000436	0.000617	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—MAG—Parkinson's disease	0.000436	0.000617	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—DRD3—Parkinson's disease	0.000433	0.000613	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—HTR7—Parkinson's disease	0.000431	0.000611	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—DRD2—Parkinson's disease	0.000431	0.000611	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—FGB—Parkinson's disease	0.000427	0.000604	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—HTR2A—Parkinson's disease	0.000426	0.000603	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—HTR1A—Parkinson's disease	0.000424	0.000601	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000421	0.000596	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—TAC1—Parkinson's disease	0.000418	0.000592	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—DRD1—Parkinson's disease	0.00041	0.00058	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000404	0.000573	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PDYN—Parkinson's disease	0.000399	0.000565	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—DRD3—Parkinson's disease	0.000397	0.000562	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—DRD2—Parkinson's disease	0.000392	0.000555	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—HTR7—Parkinson's disease	0.000392	0.000555	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000387	0.000548	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—GFAP—Parkinson's disease	0.000375	0.000531	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—ADRBK1—Parkinson's disease	0.000371	0.000525	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—GRM5—Parkinson's disease	0.000371	0.000525	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—HTR7—Parkinson's disease	0.000359	0.000508	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—DRD2—Parkinson's disease	0.000359	0.000508	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—EDN1—Parkinson's disease	0.000345	0.000489	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—FGF20—Parkinson's disease	0.000325	0.00046	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—ADORA2A—Parkinson's disease	0.000315	0.000446	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—EDN1—Parkinson's disease	0.000314	0.000444	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000302	0.000428	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—IGF2—Parkinson's disease	0.000301	0.000426	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—INSR—Parkinson's disease	0.000291	0.000412	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—IGF1R—Parkinson's disease	0.000291	0.000412	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—EDN1—Parkinson's disease	0.000287	0.000407	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000276	0.000391	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—FGB—Parkinson's disease	0.000275	0.000389	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—HTR2A—Parkinson's disease	0.000274	0.000388	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—HTR1A—Parkinson's disease	0.000273	0.000387	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—TAC1—Parkinson's disease	0.000269	0.000381	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000265	0.000375	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—NGF—Parkinson's disease	0.000264	0.000374	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—DRD1—Parkinson's disease	0.000264	0.000374	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—DRD3—Parkinson's disease	0.000256	0.000362	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—HTR2A—Parkinson's disease	0.000251	0.000356	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—ADRBK1—Parkinson's disease	0.000239	0.000338	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—APOE—Parkinson's disease	0.000234	0.000331	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—HTR7—Parkinson's disease	0.000231	0.000328	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—DRD2—Parkinson's disease	0.000231	0.000328	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.00023	0.000326	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000221	0.000313	CbGpPWpGaD
Baclofen—Chlorpropamide—ABCB1—Parkinson's disease	0.000214	0.629	CrCbGaD
Baclofen—GABBR2—Signaling Pathways—INS—Parkinson's disease	0.0002	0.000283	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—IGF2—Parkinson's disease	0.000194	0.000275	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—IGF1R—Parkinson's disease	0.000187	0.000265	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—EDN1—Parkinson's disease	0.000185	0.000262	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—NGF—Parkinson's disease	0.00017	0.000241	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—HTR2A—Parkinson's disease	0.000162	0.000229	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—APOE—Parkinson's disease	0.000151	0.000213	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CASP3—Parkinson's disease	0.000149	0.000211	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—IL6—Parkinson's disease	0.000148	0.000209	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—MAPK8—Parkinson's disease	0.000137	0.000193	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—INS—Parkinson's disease	0.000129	0.000182	CbGpPWpGaD
Baclofen—Ibuprofen—ABCB1—Parkinson's disease	0.000126	0.371	CrCbGaD
Baclofen—GABBR1—Signaling Pathways—CASP3—Parkinson's disease	9.58e-05	0.000136	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—IL6—Parkinson's disease	9.52e-05	0.000135	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—MAPK8—Parkinson's disease	8.81e-05	0.000125	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—IL6—Parkinson's disease	8.73e-05	0.000124	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—IL6—Parkinson's disease	5.62e-05	7.96e-05	CbGpPWpGaD
